Kala Bio Inc (NAS:KALA)
$ 6.865 0.0486 (0.71%) Market Cap: 19.34 Mil Enterprise Value: 4.63 Mil PE Ratio: 0 PB Ratio: 2.51 GF Score: 51/100

Kala Pharmaceuticals Inc at BofA Securities 2021 Healthcare Conference (Virtual) Transcript

May 13, 2021 / 08:15PM GMT
Release Date Price: $254.5 (-6.95%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Good afternoon, everyone. Thank you for joining us on day 3 of the Bank of America Healthcare Conference. It is my pleasure to have with me our next presenting company, Kala Pharmaceuticals. I have several members of the management team with us for the next 30 minutes. I'll start off by introducing CEO, Mark Iwicki. Mark, good afternoon.

Mark T. Iwicki
Kala Pharmaceuticals, Inc. - Chairman, President & CEO

Tazeen, thank you very much for making the time for us today, and thanks to everyone who's attending. And with me today, I have Todd Bazemore, our Chief Operating Officer; Mary Reumuth, our Chief Financial Officer; and Kim Brazzell, our Chief Medical Officer.

Tazeen Ahmad
BofA Securities, Research Division - VP

Welcome, everyone. Thanks so much for joining. So Mark, we usually try to start out the conversation with a broad overview. So in 2 minutes or less, if you could tell anyone who's listening on the phone or on the webcast about the platform, and we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot